From: Presentation and management of N-acetylglutamate synthase deficiency: a review of the literature
References | Onset | NAGS activity without argininea | NAGS activity with arginineb | Confirmed with DNA |
---|---|---|---|---|
Cases | ||||
[3] | Neonatal | 0% | Not reported | Â |
[68] (Pt 7) | Neonatal | 15% (not given in Uc) | Not stimulated | Â |
[68] (Pt 8) | Neonatal | 10% (not given in U) | Not stimulated | Â |
[68] (Pt 9) | Neonatal | 34% (not given in U) | Stimulated | Â |
[25] | Neonatal | 0% | 2% 0.44Â nmol/min/g protein (Refs. [22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49,50,51,52]) | Â |
[69] (Fam 1) | Neonatal | 10U = 29% | 20U = 14% | √ |
[70] (Proband) | Neonatal | 141U = 100% | 74U = 51% | √ |
[35] (Pt TD) | Neonatal | 78U = 100% | 104U = 72% |  |
[35] (Pt YD) | Neonatal | 98U = 100% | 64U = 44% | √ |
[26] | Neonatal |  < 10% not calculable | Not stimulated |  |
[27] (Fam 1) | Neonatal | 6U = 18% | 14U = 10% | √ |
[27] (Fam 3) | Neonatal | 14U = 41% | 9U = 6% |  |
[27] (Fam 6) | Neonatal | 0U = 0% | 72U = 50% | √ |
[36] | Neonatal | 2.1Â nmol/min/g protein (Ref. not given) | 4% 2.5Â nmol/min/g protein (control:62.8) | Â |
[28] (Case 1) | 5Â weeks | 0% not detectable | Not reported | Â |
[38] | 5 months | Not reported | 55U = 38% |  |
[15] (Patient IV-5) | 13 months | Not reported | 47.9U = 33% |  |
[14] | 3 years | 94U = 100% | 197U = 100% | √ |
[12] | 4 years | 9U = 26% | Stimulated (below ref.) |  |
[22] | 4 years | 27% 110 nmol/min/g protein (control: 1160 ± 750) | Not reported |  |
[11] | 12 years | 22U = 65% | 22U = 15% | √ |
[20] | 12 years | 30U = 88% | 46U = 32% |  |
[16] | 20 years | 14.3U = 42% | 21.4U = 15% | √ |
[18] (No 11) | 40 years | 5% (not given in U) | 4% (not given in U) | √ |
[18] (No 18) | Late | 50% (not given in U) | 75% (not given in U) | √ |
Carriers | ||||
[35] (Pt AD) | N/A | 12U = 35% | 62U = 43% | √ |
[71] (Pt 2) | N/A | 12U = 35% | 12U = 8% | √ |
[71] (Pt 3) | N/A | 8U = 24% | 32U = 22% | √ |